Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization

Loretta G. McNatt, Lori Weimer, John Yanni, Abbot F. Clark

Research output: Contribution to journalArticlepeer-review

77 Scopus citations


Ocular neovascular diseases represent a major cause of blindness in the world. Angiostatic steroids are a unique class of compounds which inhibit the formation of new blood vessels in various models, including ocular models of angiogenesis. In search of potent new anti-angiogenic agents for the treatment of ocular neovascular disease, a large group of steroids were evaluated for angiostatic activity in the chick embryo CAM model. Angiostatic activity was found among all steroid classes included in the study. There was a good correlation between the angiostatic efficacies of 15 diverse steroids tested in the chick CAM and in the rabbit LPS-induced corneal pocket models of neovascularization (r=0.76, p=0.01). These studies show that potent angiostatic steroids inhibit neovascularization in two different animal models, suggesting a common mechanism of action. Glucocorticoid therapy is sometimes associated with ocular side effects. Two of the most potent angiostatic steroids, AL-3789 and AL-4940, were evaluated for glucocorticoid- mediated anti-inflammatory activity in the in vitro U937 cell model of LPS- induced IL-1 induction and found to be devoid of glucocorticoid activity. Angiostatic steroids which lack glucocorticoid activity should be attractive drug candidates for treating ocular neovascular disease.

Original languageEnglish
Pages (from-to)413-423
Number of pages11
JournalJournal of Ocular Pharmacology and Therapeutics
Issue number5
StatePublished - Oct 1999


Dive into the research topics of 'Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization'. Together they form a unique fingerprint.

Cite this